Corrigendum to: “Monascus purpureus for statin and ezetimibe intolerant heterozygous familial hypercholesterolaemia patients: A clinical study” [Atherosclerosis (Supplements) 30C (2017) 86–91]
Claudia Stefanutti,
Fabio Mazza,
Dario Mesce,
Claudia Morozzi,
Serafina Di Giacomo,
Marco Vitale,
Mario Pergolini
Affiliations
Claudia Stefanutti
Extracorporeal Therapeutic Techniques, Lipid Clinic and Atherosclerosis Prevention Centre, Department of Molecular Medicine, University of Rome‘Sapienza’, Umberto I Hospital, Rome, Italy; Corresponding author. Extracorporeal Therapeutic Techniques Unit, Lipid Clinic and Atherosclerosis Prevention Centre, Immunohematology and Transfusion Medicine, Department of Molecular Medicine, ‘Sapienza’ University of Rome, ‘Umberto I’ Hospital, 155, Viale del Policlinico, Rome, Italy.
Fabio Mazza
Extracorporeal Therapeutic Techniques, Lipid Clinic and Atherosclerosis Prevention Centre, Department of Molecular Medicine, University of Rome‘Sapienza’, Umberto I Hospital, Rome, Italy
Dario Mesce
Extracorporeal Therapeutic Techniques, Lipid Clinic and Atherosclerosis Prevention Centre, Department of Molecular Medicine, University of Rome‘Sapienza’, Umberto I Hospital, Rome, Italy
Claudia Morozzi
Extracorporeal Therapeutic Techniques, Lipid Clinic and Atherosclerosis Prevention Centre, Department of Molecular Medicine, University of Rome‘Sapienza’, Umberto I Hospital, Rome, Italy
Serafina Di Giacomo
Extracorporeal Therapeutic Techniques, Lipid Clinic and Atherosclerosis Prevention Centre, Department of Molecular Medicine, University of Rome‘Sapienza’, Umberto I Hospital, Rome, Italy
Marco Vitale
Extracorporeal Therapeutic Techniques, Lipid Clinic and Atherosclerosis Prevention Centre, Department of Molecular Medicine, University of Rome‘Sapienza’, Umberto I Hospital, Rome, Italy
Mario Pergolini
Department of Internal Medicine and Medical Specialties, University of Rome ‘Sapienza’, Umberto I Hospital, Rome, Italy
